TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer.
about
DNA methylation changes in epithelial ovarian cancer histotypes.The multiple facets of drug resistance: one history, different approaches.Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.Lack of association between MTHFD1 G401A polymorphism and ovarian cancer susceptibility.Gallotannin imposes S phase arrest in breast cancer cells and suppresses the growth of triple-negative tumors in vivo.Epigenetic regulation of inflammatory cytokines and associated genes in human malignanciesEWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma.Transforming growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer.Meta-analysis of differences in Constant-Murley scores for three mid-shaft clavicular fracture treatments.Integration and bioinformatics analysis of DNA-methylated genes associated with drug resistance in ovarian cancer.Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma.Secreted frizzled related protein 1 modulates taxane resistance of human lung adenocarcinoma.Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer.Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell linesBigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model.Prediction of therapy response in ovarian cancer: Where are we now?The role of TGFBI (βig-H3) in gastrointestinal tract tumorigenesis.Aberrant DNA methylation of GATA binding protein 3 (GATA3), interleukin-4 (IL-4), and transforming growth factor-β (TGF-β) promoters in Behcet's disease.Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma.
P2860
Q27690722-C19B1CE4-CC1D-4C89-946E-320277070E90Q33697116-6522AEC8-FC03-407A-9D11-FDCBE46211E2Q34168437-04221900-EE88-447E-877F-7336F1347757Q34544542-042C6C05-9451-439A-8A17-9A5C9BE328A5Q35056269-71E5E224-BBB7-4670-8C3F-B893469DA25FQ35128160-E5BAE958-5084-43FF-883C-6FF769EB67D7Q35178132-B43FD7B2-D8F8-4639-B4BB-451EED910F41Q35820934-9449BBF3-BA0C-4EDC-8AD0-B8307690D86CQ36202508-64565A15-8127-4BF8-A422-72A3A48FB6C1Q36406928-FE6E3554-FB1F-4545-AA7F-50324046ACE0Q37000936-46554DC9-8CA6-4BF1-B756-C5D86C28CAE1Q37006888-E5880226-220C-41CC-81B9-AF977B9C7732Q37728993-42659B94-DBBA-4551-8998-7FCAF2FD2949Q38544386-978D6AFE-CF22-4EA6-B088-412F3A321E6CQ38700421-C58B4F87-CB15-4BDE-958A-544FFC92EEBDQ39014286-1A345085-22B3-457E-87E3-1F338EECD819Q39263260-88F47B4F-B471-4EE5-A289-11B73B4E781FQ40786475-B1C85BB8-2F63-40D0-B0FB-02F8D7A06EB9Q42362787-22FD5D6D-4EAC-4962-996E-A1CFA6ED0E58Q55001674-4841F28D-C3DD-4AF5-930B-DE8370870B03
P2860
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
TGFBI promoter hypermethylatio ...... oresistance in ovarian cancer.
@ast
TGFBI promoter hypermethylatio ...... oresistance in ovarian cancer.
@en
type
label
TGFBI promoter hypermethylatio ...... oresistance in ovarian cancer.
@ast
TGFBI promoter hypermethylatio ...... oresistance in ovarian cancer.
@en
prefLabel
TGFBI promoter hypermethylatio ...... oresistance in ovarian cancer.
@ast
TGFBI promoter hypermethylatio ...... oresistance in ovarian cancer.
@en
P2093
P2860
P356
P1476
TGFBI promoter hypermethylatio ...... oresistance in ovarian cancer.
@en
P2093
Shuzhen Dai
Xingsheng Yang
Yankui Wang
P2860
P2888
P356
10.1186/1756-9966-31-6
P577
2012-01-16T00:00:00Z
P5875
P6179
1053307477